Victrex (VTXPF) Downgraded by ValuEngine
ValuEngine downgraded shares of Victrex (OTCMKTS:VTXPF) from a buy rating to a hold rating in a research note issued to investors on Thursday.
Separately, Zacks Investment Research raised Victrex from a sell rating to a hold rating in a research note on Thursday, August 16th.
Victrex stock opened at $34.95 on Thursday. Victrex has a fifty-two week low of $31.49 and a fifty-two week high of $45.68.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.
Featured Article: Should I invest in “strong buy” stocks?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.